EarLens
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $4.6m | Series A | |
N/A | $500k | Seed | |
N/A | $1.6m | Debt | |
$40.0m | Series B | ||
$34.0m | Series C | ||
$45.0m | Debt | ||
$87.0m | Series D | ||
$73.0m | Series C | ||
N/A | $33.2m | - | |
* | N/A | $21.2m | Late VC |
* | N/A | $18.8m | Late VC |
Total Funding | AUD483m |
Related Content
Recent News about EarLens
EditEarlens operates in the hearing aid market, offering a unique hearing solution that uses a small lens placed directly on the eardrum to vibrate and activate the natural hearing process. This method provides a more complete and natural sound compared to traditional hearing devices. The company's products are custom-fitted by physicians and audiologists, ensuring a comprehensive medical approach to hearing loss. Earlens serves clients who suffer from hearing loss and are looking for premium, personalized hearing care. The business model involves selling these advanced hearing solutions through select practices across the United States. Revenue is generated through the sale of the hearing devices and associated medical services.
Keywords: hearing aid, eardrum lens, natural sound, hearing loss, custom-fit, premium care, medical approach, audiologist, physician, U.S. market.